Algatech licenses innovative technology to launch Euglena-derived products. Through its development of this new technology, Algatech’s vision is to bring these more efficient and better quality β-1,3-glucans-based products to market. In order to capitalise on the wide-reaching benefits of microalgae derived β-1,3-glucans and a largely untapped market, Algatech is planning to launch several products using the nutrient for both the human and animal health markets in the coming months.
FucoVitalTM is the only 3% fucoxanthin extract that targets the first stage of fatty liver by reducing the simple accumulation of fat in the liver. Algatech’s FucoVitalTM is, the first fucoxanthin derived from microalgae and is cultivated year-round in an industrial closed and controlled system, fully exposed to natural sunlight
It was only a matter of time until NASA (National Aeronautics and Space Administration U.S.A.) began to study the benefits of taking microalgae into space. Consider the resilience of microalgae combined with the many potential health benefits they can provide to the astronauts. Recently, NASA has been testing the growth of microalgae in space for its potential use during long-duration space missions as a source of nutrition, oxygen, waste removal and potentially biofuel.